05/17/2024 4:15 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
05/01/2024 4:05 PM | Iovance Biotherapeutics (Filer)
| Form ARS | |
04/29/2024 4:06 PM | Iovance Biotherapeutics (Filer)
| Form DEF 14A | |
04/29/2024 4:07 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
04/17/2024 6:07 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 6:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 6:08 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/29/2024 4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 5:19 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:20 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:17 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:58 PM | Iovance Biotherapeutics (Issuer) YARNO WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:50 PM | Countouriotis Athena (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:51 PM | Bellemin Jean-Marc (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:52 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 7:00 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 6:09 PM | Iovance Biotherapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
02/29/2024 6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 3:05 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 3:44 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
02/20/2024 6:52 PM | Iovance Biotherapeutics (Issuer) MCPEAK MERRILL A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:23 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 5:03 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 5:16 AM | Iovance Biotherapeutics (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024 4:40 PM | Iovance Biotherapeutics (Subject) MHR FUND MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/25/2024 9:49 AM | Iovance Biotherapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024 5:07 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 5:09 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 5:09 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023 3:24 PM | Iovance Biotherapeutics (Subject) Quogue Capital LLC (Filed by)
| Form SC 13D/A | |
10/18/2023 7:03 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 7:04 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/18/2023 7:05 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 3:30 PM | Iovance Biotherapeutics (Issuer) MCPEAK MERRILL A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 5:12 PM | Iovance Biotherapeutics (Issuer) Rothbaum Wayne P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 7:17 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/18/2023 4:16 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Did You Get Your Free Bitcoin Yet? (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
07/17/2023 5:21 PM | BILINSKY IGOR (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2023 5:22 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2023 5:22 PM | Iovance Biotherapeutics (Issuer) Vogt Frederick G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 3:31 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2023 4:08 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
07/11/2023 3:55 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 4:27 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
07/10/2023 3:40 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2023 7:53 AM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 3:51 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 3:39 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
06/16/2023 3:11 PM | Iovance Biotherapeutics (Filer)
| Form S-3ASR | |
06/08/2023 5:20 PM | Iovance Biotherapeutics (Issuer) YARNO WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:20 PM | Dukes Iain D. (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:21 PM | Iovance Biotherapeutics (Issuer) WEISER MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:21 PM | Iovance Biotherapeutics (Issuer) Maynard Ryan D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:21 PM | Iovance Biotherapeutics (Issuer) MCPEAK MERRILL A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:22 PM | Countouriotis Athena (Reporting) Iovance Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2023 4:17 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 3:30 PM | Iovance Biotherapeutics (Filer)
| Form 8-K/A | |
05/26/2023 7:38 PM | Iovance Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |